UBS Group AG - PLUS THERAPEUTICS INC ownership

PLUS THERAPEUTICS INC's ticker is PSTV and the CUSIP is 72941H400. A total of 20 filers reported holding PLUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of PLUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4
-99.9%
13
-99.9%
0.00%
Q4 2022$6,081
-13.1%
19,003
+17.2%
0.00%
Q3 2022$7,0000.0%16,208
+18.4%
0.00%
Q2 2022$7,00013,688
+105192.3%
0.00%
Q1 2022$0130.0%0.00%
Q4 2021$0130.0%0.00%
Q3 2021$0130.0%0.00%
Q2 2021$0130.0%0.00%
Q1 2021$0130.0%0.00%
Q4 2020$0130.0%0.00%
Q3 2020$013
+550.0%
0.00%
Q3 2019$020.00%
Other shareholders
PLUS THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
B. Riley Wealth Management, Inc. 12,000$29,0000.00%
Creative Planning 16,356$39,0000.00%
VANGUARD GROUP INC 77,086$185,0000.00%
UBS Group AG 13$00.00%
OSAIC HOLDINGS, INC. 8,005$19,0000.00%
Wealthcare Advisory Partners LLC 1$00.00%
BANK OF AMERICA CORP /DE/ 1,400$3,0000.00%
WELLS FARGO & COMPANY/MN 60$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 21$00.00%
View complete list of PLUS THERAPEUTICS INC shareholders